Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 2009;120:S238-S246
doi: 10.1161/CIRCULATIONAHA.109.885236
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Data Supplement
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Wang, X.
Right arrow Articles by Zhang, J.
PubMed
Right arrow Articles by Wang, X.
Right arrow Articles by Zhang, J.
Related Collections
Right arrow Biochemistry and metabolism
Right arrow Congestive
Right arrow Remodeling
Right arrow Animal models of human disease
Right arrow CT and MRI
Right arrow CV surgery: coronary artery disease
Right arrow Chronic ischemic heart disease

(Circulation. 2009;120:S238-S246.)
© 2009 American Heart Association, Inc.


Cell Transplantation and Tissue Regeneration

Stem Cells for Myocardial Repair With Use of a Transarterial Catheter

Xiaohong Wang, MD, PhD; Mohammad Nurulqadr Jameel, MD; Qinglu Li, BS; Abdul Mansoor, MD, PhD; Xiong Qiang, MS; Cory Swingen, PhD; Carmelo Panetta, MD; Jianyi Zhang, MD, PhD

From the Department of Medicine, University of Minnesota Medical School, Minneapolis, Minn.

Correspondence to Jianyi Zhang, MD, PhD, University of Minnesota Health Science Center, Mayo Mail Code 508, 420 Delaware St SE, Minneapolis, MN 55455. E-mail zhang047{at}umn.edu

Background— Using a swine model of postinfarction left ventricle (LV) remodeling, we investigated marrow-derived, multipotent progenitor cell (MPC) transplantation into hearts with acute myocardial infarction (AMI) via a novel transarterial catheter.

Methods and Results— The left anterior descending coronary artery was balloon-occluded after percutaneous transluminal angiography to generate AMI (60-minute no-flow ischemia). The transarterial catheter was then placed in the same coronary artery, and either 50x106 MPCs (cell group, n=6) or saline (control, n=6) was injected into the border zone (BZ) myocardium. LV function was assessed by magnetic resonance imaging before AMI and at 1 and 4 weeks after AMI, whereas myocardial energy metabolism was assessed by 31P-magnetic resonance spectroscopy at week 4. One week after AMI, the ejection fraction was significantly reduced in both groups from a baseline of {approx}50% to 31.3±3.9% (cell group) and 33.3±3.1% (control). However, at week 4, the cell group had a significant recovery in ejection fraction. The functional improvements were accompanied by a significant improvement in myocardial bioenergetics. Histologic data demonstrated a 0.55% cell engraftment rate 4 weeks after MPC transplantation. Only 2% of engrafted cells were costaining positive for cardiogenic markers. Vascular density in the BZ was increased in the cell group. Conditioned medium from cultured MPCs contained high levels of vascular endothelial growth factor, which was increased in response to hypoxia. MPCs cocultured with cardiomyocytes inhibited changes in cardiomyocyte mitochondrial membrane potential and cytochrome c release induced by tumor necrosis factor-{alpha}.

Conclusions— Thus, a paracrine effect may contribute significantly to the observed therapeutic effects of MPC transplantation.


Key Words: stem cells • metabolism • myocardial infarct